Moderna Inc (MRNA : NASDAQ)
Common Stock
$145.62
USD
+1.85 (1.29%)
Last updated: 2026-09-16
Get MRNA alerts:
MRNA
Moderna Inc
WealthAwesomePerformance
1 Day
+1.29%
1 Week
+7.38%
1 Month
+125.91%
YTD
+135.63%
Key Statistics
Market Cap
$58.14B
52W High
$176.66
52W Low
$22.28
P/E Ratio
-
50 Day MA
$93.61
200 Day MA
$58.34
Beta
1.11
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/16/2026 | $145.26 | $148.93 | $142.30 | $145.62 | $145.62 | 8,832,059 |
| 9/15/2026 | $146.00 | $148.70 | $141.16 | $143.77 | $143.77 | 8,414,700 |
| 9/14/2026 | $144.93 | $147.34 | $139.02 | $146.69 | $146.69 | 10,963,000 |
| 9/11/2026 | $137.91 | $149.73 | $135.01 | $143.97 | $143.97 | 15,409,300 |
| 9/10/2026 | $134.86 | $137.13 | $130.38 | $136.62 | $136.62 | 7,873,500 |
| 9/9/2026 | $140.29 | $143.94 | $135.52 | $135.61 | $135.61 | 8,650,500 |
| 9/8/2026 | $145.98 | $147.50 | $139.70 | $140.33 | $140.33 | 10,308,600 |
| 9/4/2026 | $153.62 | $154.69 | $141.52 | $145.55 | $145.55 | 14,966,500 |
| 9/3/2026 | $145.94 | $150.20 | $142.78 | $148.87 | $148.87 | 13,290,400 |
| 9/2/2026 | $151.40 | $156.41 | $146.54 | $150.81 | $150.81 | 16,563,200 |
Analyst Price Targets
Based on 27 analysts covering MRNA · as of Sep 17, 2026
Wall Street analysts forecast MRNA stock price to fall 17.9% over the next 12 months.
Consensus
Hold3.22 / 5.00
Avg. Target
US$119.56
-17.9% Upside
Current Price
US$145.62
Last close
Analyst Breakdown (27 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRNA's historical volatility
30-Day Vol
315.5%
Annualized
90-Day Vol
226.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$174.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$154.55 | US$52.03 – US$459.10 |
| 60 trading days | US$164.03 | US$35.17 – US$764.91 |
| 90 trading days | US$174.09 | US$26.41 – US$1147.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Financials
- Revenue (TTM)
- $2.23B
- EBITDA
- $-2.20B
- Profit Margin
- -141.43%
- ROE (TTM)
- -39.00%
- EPS (Diluted)
- -8.08
- Book Value
- 16.95
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MRNA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |
MRNA.US news timeline
1 article covering MRNA.US, most recent first
Latest